Financials Immix Biopharma, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
7.070 ^USD	-4.20%		+27.16%	+221.36%

Dec. 09	Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants	RE
Dec. 08	Immix Biopharma Prices $100 Million Offering	MT

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net sales ¹	-	-	-	-	-	-
Change	-	-	-	-	-	-
EBITDA ¹	-	-8.217	-16.14	-	-25.78	-24.32
Change	-	-	-96.37%	-	-	5.66%
EBIT ¹	-	-8.219	-16.14	-22.67	-26.44	-30.53
Change	-	-	-96.39%	-40.48%	-16.6%	-15.47%
Interest Paid	-	-0.0005	-	-	-	-1.196
Earnings before Tax (EBT) ¹	-	-8.219	-15.57	-21.66	-25.52	-30.44
Change	-	-	-89.42%	-39.1%	-17.83%	-19.29%
Net income ¹	-24.38	-8.23	-15.43	-21.61	-25.52	-30.46
Change	-	66.25%	-87.44%	-40.11%	-18.07%	-19.36%
Announcement Date	3/28/22	3/27/23	3/29/24	3/25/25	-	-

¹USD in Million

Estimates

Fiscal Period: December	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales ¹	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	-	-3.795	-2.521	-3.721	-4.524	-5.376	-5.59	-4.702	-7.395	-4.987	-	-6.718	-7.663	-7.862	-8.066	-8.276	-9.406	-10.84
Change	-	-	33.57%	-47.6%	-21.58%	-18.83%	-3.99%	15.88%	-57.26%	32.56%	-	-	-14.06%	-2.6%	-2.59%	-2.6%	-13.65%	-15.19%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-3.795	-2.493	-3.592	-4.337	-5.147	-5.322	-4.396	-7.138	-4.801	-	-6.614	-7.578	-7.39	-7.666	-7.976	-9.206	-10.74
Change	-	-	34.3%	-44.09%	-20.75%	-18.68%	-3.4%	17.41%	-62.4%	32.74%	-	-	-14.58%	2.48%	-3.73%	-4.04%	-15.42%	-16.61%
Net income ¹	-1.535	-3.8	-2.48	-3.576	-4.281	-5.09	-5.259	-4.393	-7.149	-4.812	-	-6.623	-7.586	-7.39	-7.666	-7.976	-9.206	-10.74
Change	-	-147.54%	34.74%	-44.22%	-19.7%	-18.9%	-3.33%	16.47%	-62.75%	32.69%	-	-	-14.54%	2.58%	-3.73%	-4.04%	-15.42%	-16.61%
Announcement Date	11/9/22	3/27/23	5/12/23	8/11/23	11/13/23	3/29/24	5/9/24	8/12/24	11/12/24	3/25/25	5/8/25	8/8/25	11/7/25	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-13.4	-17.5	-	7.31	-14.2
Change	-	-	-30.6%	-	-	-294.25%
Announcement Date	3/28/22	3/27/23	3/29/24	3/25/25	-	-

¹USD in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026
CAPEX ¹	-	0.0521	1.178	-	-
Change	-	-	2,160.86%	-100%	-
Free Cash Flow (FCF) ¹	-	-	-	-	-
Change	-	-	-	-	-
Announcement Date	3/27/23	3/29/24	3/25/25	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	-	-	-	-	-	-	-
EBIT Margin (%)	-	-	-	-	-	-	-
EBT Margin (%)	-	-	-	-	-	-	-
Net margin (%)	-	-	-	-	-	-	-
FCF margin (%)	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-
Profitability
ROA	-23.5%	-9.02%	-31.04%	-57.92%	-66.11%	-	-
ROE	24.46%	-367.8%	-52.84%	-106.22%	-147.33%	-	-
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-0.28x	-
Debt / Free cash flow	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	-	-	-	-	-	-
CAPEX / EBITDA (%)	-	-	-	-0.32%	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-
EPS ¹	-	-6.64	-0.59	-0.89	-0.76	-0.775	-0.685
Change	-	-	91.11%	-50.85%	14.61%	-1.97%	11.61%
Nbr of stocks (in thousands)	-	13,209	13,927	19,867	27,508	33,578	33,578
Announcement Date	-	3/28/22	3/27/23	3/29/24	3/25/25	-	-